Nordson Corp (NDSN) Q1 2026 Earnings Call Transcript

Why It Matters

The results underscore Nordson’s expanding role in semiconductor packaging, boosting profitability and financial flexibility for strategic acquisitions and continued shareholder returns.

Key Takeaways

• Record Q1 revenue $669M, up 9% YoY
• ATS sales +23% driven by semiconductor demand
• Free cash flow $123M, 105% net income conversion
• Leverage 2.1x, $800M credit facility capacity
• Full‑year revenue guidance raised to $2.98B

Pulse Analysis

Nordson’s first‑quarter performance highlights the accelerating demand for semiconductor‑related solutions, a trend fueled by AI‑driven chip designs and increasingly complex packaging. The Advanced Technology Solutions (ATS) segment, which now generates roughly half of its revenue from semiconductor applications, posted a 23% sales surge and a 43% jump in EBITDA. This growth reflects Nordson’s strategic focus on precision dispense and X‑ray inspection technologies that enable higher‑density chip stacking and quality control, positioning the company as a critical partner in the evolving semiconductor supply chain.

Financially, Nordson delivered a robust top‑line expansion while maintaining a 30% EBITDA margin, despite lower‑margin system sales in Asia. Free cash flow surpassed $120 million, translating to a 105% conversion rate, and the firm allocated $128 million to dividends and share repurchases, reinforcing its commitment to shareholder value. A net‑debt level of $1.9 billion and a leverage ratio of 2.1× remain within long‑term targets, while a refreshed $1.2 billion credit facility provides ample liquidity for potential acquisitions and continued investment in growth initiatives.

Looking ahead, Nordson’s order backlog grew modestly, and the company raised its full‑year revenue outlook by up to 4.5%, anticipating continued momentum in ATS and steady performance across its Industrial Precision Solutions and Medical & Fluid Solutions segments. The expanded credit facility and disciplined balance‑sheet management give Nordson flexibility to pursue strategic M&A, particularly in medical, testing, and core industrial technologies. As semiconductor demand intensifies and new packaging challenges emerge, Nordson’s technology portfolio and geographic footprint—especially in Asia‑Pacific—are well‑positioned to capture further upside, supporting sustained earnings growth throughout fiscal 2026.